Inhibition of Inflammation-Associated Olfactory Loss by Etanercept in an Inducible Olfactory Inflammation Mouse Model

Pharmacogenetics and Future Therapeutic Scenarios: What Affects the Prediction of Response to Treatment with Etanercept?

(2014) Giuseppe Murdaca et al.   DRUG DEVELOPMENT RESEARCH

Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases

(2014) Lesley J. Scott   DRUGS

New treatments for inflammatory rheumatic disease

(2014) Carlo Selmi et al.   IMMUNOLOGIC RESEARCH

Etanercept Reduces Neuroinflammation and Lethality in Mouse Model of Japanese Encephalitis

(2014) Jing Ye et al.   JOURNAL OF INFECTIOUS DISEASES

Does post-infectious olfactory loss affect mood more severely than chronic sinusitis with olfactory loss?

(2014) Yong G. Jung et al.   LARYNGOSCOPE

Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma

(2013) Ozge Yilmaz et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Interferon gamma causes olfactory dysfunction without concomitant neuroepithelial damage

(2013) Tatyana Pozharskaya et al.   International Forum of Allergy & Rhinology

The role of TNF-α in inflammatory olfactory loss

(2011) Babar Sultan et al.   LARYNGOSCOPE

Reversible Loss of Neuronal Marker Protein Expression in a Transgenic Mouse Model for Sinusitis-Associated Olfactory Dysfunction

(2010) Justin H. Turner et al.   American Journal of Rhinology & Allergy

Tumor Necrosis Factor-α Antagonist Etanercept Decreases Blood Pressure and Protects the Kidney in a Mouse Model of Systemic Lupus Erythematosus

(2010) Marcia Venegas-Pont et al.   HYPERTENSION

A Genetic Model of Chronic Rhinosinusitis-Associated Olfactory Inflammation Reveals Reversible Functional Impairment and Dramatic Neuroepithelial Reorganization

(2010) A. P. Lane et al.   JOURNAL OF NEUROSCIENCE